Veerhealth Care

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE882C01035
  • NSEID: NIYATILEAS
  • BSEID: 511523
INR
49.67
-0.29 (-0.58%)
BSENSE

Sep 22, 03:30 PM

BSE+NSE Vol: 1.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Makers Labs.
Vaishali Pharma
Veerhealth Care
Concord Drugs
Parmax Pharma
Mercury Labs
Sotac Pharma.
Denis Chem Lab
Tyche Industries
Pharmaids Pharma
Asston Pharmaceu

Why is Veerhealth Care Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.92%
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.28
2
With a growth in Operating Profit of 117.89%, the company declared Very Positive results in Jun 26
  • The company has declared positive results for the last 6 consecutive quarters
  • PBT LESS OI(Q) At Rs 1.32 cr has Grown at 604.0% (vs previous 4Q average)
  • NET SALES(Latest six months) Higher at Rs 41.69 cr
  • PBDIT(Q) Highest at Rs 1.91 cr.
3
With ROCE of 4.4, it has a Very Expensive valuation with a 3.8 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 170.98%, its profits have risen by 133% ; the PEG ratio of the company is 0.2
4
Majority shareholders : Non Institution
5
Market Beating performance in long term as well as near term
  • Along with generating 170.98% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Veerhealth Care should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Veerhealth Care for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Veerhealth Care
170.98%
5.48
31.20%
Sensex
-9.29%
-0.69
13.52%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
35.92%
EBIT Growth (5y)
35.45%
EBIT to Interest (avg)
0.28
Debt to EBITDA (avg)
1.67
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.70
Tax Ratio
38.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-0.10%
ROE (avg)
2.92%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
54
Industry P/E
22
Price to Book Value
4.36
EV to EBIT
34.21
EV to EBITDA
23.58
EV to Capital Employed
3.85
EV to Sales
1.96
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
4.36%
ROE (Latest)
8.03%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company
PBT LESS OI(Q)

At Rs 1.32 cr has Grown at 604.0% (vs previous 4Q average

NET SALES(Latest six months)

Higher at Rs 41.69 cr

PBDIT(Q)

Highest at Rs 1.91 cr.

PAT(Q)

Highest at Rs 1.23 cr.

EPS(Q)

Highest at Rs 0.62

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Veerhealth Care

Net Sales - Latest six months
At Rs 41.69 cr has Grown at 312.36%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1.32 cr has Grown at 604.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 0.19 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1.23 cr has Grown at 811.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.14 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Latest six months
Higher at Rs 41.69 cr
than preceding 12 month period ended Jun 2026 of Rs 21.35 cr
MOJO Watch
In the half year the company has already crossed sales of the previous twelve months

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1.91 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.32 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 1.23 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.62
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)